STOCK TITAN

British American Tobacco (NYSE: BTI) outlines November voting and share transactions

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

British American Tobacco p.l.c. filed a Form 6-K summarizing a series of November 2025 corporate announcements. The filing bundles press releases on voting rights and capital, multiple “transaction in own shares” notices, and several disclosures of transactions by senior managers and closely associated persons.

The 6-K mainly serves to make these previously published materials available to U.S. investors in one place, rather than introducing new financial results or major strategic changes.

Positive

  • None.

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does British American Tobacco (BTI) report in this Form 6-K?

British American Tobacco uses this Form 6-K to furnish a package of November 2025 press releases to U.S. investors. These cover voting rights and capital, transactions in its own shares, and notifications of dealings by senior managers and closely associated persons.

What time period does the BTI November 2025 Form 6-K cover?

The Form 6-K centers on press releases dated between November 3 and November 28, 2025. It is dated December 1, 2025, and consolidates those November announcements into a single SEC submission for easier access by U.S. market participants.

What are the ‘transaction in own shares’ notices for BTI?

The ‘transaction in own shares’ notices are press releases referenced as multiple exhibits dated throughout November 2025. They report British American Tobacco’s dealings in its own shares, providing transparency around those equity transactions to regulators and investors.

What managerial transaction disclosures are included for BTI in this filing?

Several exhibits are press releases titled as notifications and public disclosures of transactions by persons discharging managerial responsibilities and persons closely associated with them. These outline dealings in British American Tobacco securities by senior insiders and related parties in November 2025.

Does this BTI Form 6-K include voting rights information?

Yes. One exhibit is a press release titled “British American Tobacco – Voting Rights and Capital” dated November 3, 2025. It addresses the company’s voting rights and capital structure, providing governance-related information alongside other November share transaction disclosures.


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


 
FORM 6-K
 

 
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
 
December 1, 2025
 
Commission File Number: 001-38159


 
BRITISH AMERICAN TOBACCO P.L.C.
(Translation of registrant’s name into English)


 
Globe House
4 Temple Place
London WC2R 2PG
United Kingdom
(Address of principal executive office)


 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F               Form 40-F ☐
 
 
 

 

 
This report includes materials as exhibits that have been published and made available by British American Tobacco p.l.c. as of the date indicated in the relevant exhibit description.

EXHIBIT INDEX
 
Exhibit
 
Description
 
 
 
Exhibit 1

Press Release entitled “British American Tobacco p.l.c. (the “Company”) – Voting Rights and Capital” dated November 3, 2025.
     
Exhibit 2
 
Press Release entitled “Transaction in own shares” dated November 4, 2025.
     
Exhibit 3   Press Release entitled “Transaction in own shares” dated November 5, 2025.
     
Exhibit 4   Press Release entitled “Transaction in own shares” dated November 6, 2025.
     
Exhibit 5
 
Press Release entitled “British American Tobacco p.l.c. (the “Company”) – Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated November 6, 2025.
     
Exhibit 6
  Press Release entitled “Transaction in own shares” dated November 7, 2025.
     
Exhibit 7
  Press Release entitled “Transaction in own shares” dated November 10, 2025.
     
Exhibit 8   Press Release entitled “Transaction in own shares” dated November 11, 2025.
     
Exhibit 9  
Press Release entitled “British American Tobacco p.l.c. (the “Company”) – Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated November 11, 2025.
     
Exhibit 10  
Press Release entitled “British American Tobacco p.l.c. (the “Company”) – Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated November 11, 2025.
     
Exhibit 11  
Press Release entitled “British American Tobacco p.l.c. (the “Company”) – Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated November 11, 2025.
     
Exhibit 12   Press Release entitled “Transaction in own shares” dated November 12, 2025.
     
Exhibit 13
  Press Release entitled “Transaction in own shares” dated November 13, 2025.
     
Exhibit 14  
Press Release entitled “British American Tobacco p.l.c. (the “Company”) – Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated November 13, 2025.
     
Exhibit 15

Press Release entitled “Transaction in own shares” dated November 14, 2025.
     
Exhibit 16

Press Release entitled “Transaction in own shares” dated November 17, 2025.
     
Exhibit 17   Press Release entitled “Transaction in own shares” dated November 18, 2025.
     
Exhibit 18  
Press Release entitled “British American Tobacco p.l.c. (the “Company”) – Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated November 18, 2025.
     
Exhibit 19   Press Release entitled “Transaction in own shares” dated November 19, 2025.
     
Exhibit 20   Press Release entitled “Transaction in own shares” dated November 20, 2025.
     
Exhibit 21   Press Release entitled “British American Tobacco p.l.c. (the “Company”) – Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated November 20, 2025.
     
Exhibit 22   Press Release entitled “Transaction in own shares” dated November 21, 2025.
     
Exhibit 23   Press Release entitled “Transaction in own shares” dated November 24, 2025.
     
Exhibit 24   Press Release entitled “Transaction in own shares” dated November 25, 2025.
     
Exhibit 25   Press Release entitled “Transaction in own shares” dated November 26, 2025.
     
Exhibit 26   Press Release entitled “Transaction in own shares” dated November 27, 2025.
     
Exhibit 27   Press Release entitled “Transaction in own shares” dated November 28, 2025.




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
British American Tobacco p.l.c.
 
   
 
       
 
By:
/s/ Christopher Worlock
 
    Name: 
Christopher Worlock
 
    Title:   
Assistant Secretary
 
       
 
Date:  December 1, 2025